Aiosyn’s Kidney AI Suite uses deep learning to analyze kidney structures and quantify lesions that impact kidney health. Co-developed with kidney pathology experts, the platform is designed to advance research in the field of renal diseases.
Aiosyn specializes in the development of deep learning algorithms for cancer and kidney disease diagnosis and research.
We use science-based innovation to create AI-powered image analysis software, enhancing workflows and delivering certified solutions that have a positive impact on patients. Our computational pathology technology provides data-driven insights to improve clinical diagnostics and complement R&D studies.
At Aiosyn, we develop precision pathology solutions that inject deep learning algorithms into existing workflows, equipping medical professionals and researchers with data-driven insights. Our close connection to clinical practice enables us to build these solutions for and together with pathology labs and biopharma companies.
By co-developing our technology with experts and integrating modular software into standard workflows, we facilitate the adoption of AI in pathology to improve patient outcomes worldwide.